Meng Cheng
Impact in
- Biomaterials top 5%
- Nanocomposite Films for Food Packaging
- Oncology top 10%
- Peptidase Inhibition and Analysis
Papers in
-
- Epigenetics and DNA Methylation 6
- Ubiquitin and proteasome pathways 4
- RNA modifications and cancer 4
- Co-authors
- Yue Xiong (6 shared papers)Xiangyou Wang (14 shared papers)Jian Jin (3 shared papers)Rongfei Zhang (9 shared papers)H. Ümit Kanıskan (1 shared paper)Kwang‐Su Park (1 shared paper)Brandon Dale (1 shared paper)Juan Wang (8 shared papers)
- Journals
- Journal of Experimental & Clinical Cancer Research (3 papers)Frontiers in Oncology (3 papers)International Journal of Biological Macromolecules (2 papers)Frontiers in Immunology (2 papers)Journal of Medicinal Chemistry (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Meng Cheng
91 papers receiving 2.2k citations
Meng Cheng's Hit Papers
Peers
Comparison fields: 5 of 136
- Biomaterials 345
- Oncology 345
- Molecular Biology 916
- Hematology 136
- Cancer Research 140
Countries citing papers authored by Meng Cheng
This map shows the geographic impact of Meng Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Cheng more than expected).
Fields of papers citing papers by Meng Cheng
This network shows the impact of papers produced by Meng Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Cheng. The network helps show where Meng Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Meng Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Advancing targeted protein degradation for cancer therapy Hit paper breakdown → | 2021 | 458 |
| 2 | 2019 | 188 | |
| 3 | 2020 | 148 | |
| 4 | 2019 | 117 | |
| 5 | 2013 | 73 | |
| 6 | 2019 | 71 | |
| 7 | 2021 | 67 | |
| 8 | 2018 | 65 | |
| 9 | 2020 | 58 | |
| 10 | 2023 | 57 | |
| 11 | 2018 | 51 | |
| 12 | 2023 | 50 | |
| 13 | 2021 | 49 | |
| 14 | 2020 | 41 | |
| 15 | 2018 | 40 | |
| 16 | 2020 | 40 | |
| 17 | 2020 | 32 | |
| 18 | 2018 | 30 | |
| 19 | 2018 | 28 | |
| 20 | 2021 | 28 |
About Meng Cheng
Meng Cheng is a scholar working on Molecular Biology, Plant Science, Cancer Research, Biomaterials and Electrical and Electronic Engineering, having authored 98 papers that have together received 2.3k indexed citations. Recurring topics across this work include Nanocomposite Films for Food Packaging (9 papers), Cancer-related molecular mechanisms research (7 papers), Epigenetics and DNA Methylation (6 papers), Advancements in Battery Materials (6 papers), Advanced Battery Materials and Technologies (6 papers), Ubiquitin and proteasome pathways (4 papers), Advanced Photocatalysis Techniques (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Biomaterials (345 citations), Oncology (345 citations), Molecular Biology (916 citations), Hematology (136 citations) and Cancer Research (140 citations). Meng Cheng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yue Xiong, Xiangyou Wang, Jian Jin, Rongfei Zhang, H. Ümit Kanıskan, Kwang‐Su Park, Brandon Dale, Juan Wang, Yingjun Cui and Zhixiang Wei. Their work appears in journals such as Journal of Experimental & Clinical Cancer Research, Frontiers in Oncology, International Journal of Biological Macromolecules, Frontiers in Immunology and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.